Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00AWA
|
||||
| Former ID |
DIB010367
|
||||
| Drug Name |
WIN-63759
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Emphysema [ICD9: 492; ICD10:J43] | Terminated | [1] | ||
| Company |
Sterling Winthrop Group Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H28Cl2N2O8S
|
||||
| Canonical SMILES |
S1(=O)(=O)N(C(=O)c2c1cc(cc2C(C)C)OC)COC(=O)c1c(c(ccc1Cl<br />)OCCN1CCOCC1)Cl
|
||||
| CAS Number |
CAS 142427-32-5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Elastase 1 | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007449) | ||||
| REF 2 | Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase. Drug Development Research Volume 34, Issue 3, pages 306-316, March 1995. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.